Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,715 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation.
Kim DS, Kim B, Tahk H, Kim DH, Ahn ER, Choi C, Jeon Y, Park SY, Lee H, Oh SH, Kim SY. Kim DS, et al. Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):479-84. doi: 10.1016/j.bbrc.2010.11.063. Epub 2010 Nov 19. Biochem Biophys Res Commun. 2010. PMID: 21094133
I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.
Kim DS, Han BG, Park KS, Lee BI, Kim SY, Bae CD. Kim DS, et al. Biochem Biophys Res Commun. 2010 Aug 20;399(2):300-6. doi: 10.1016/j.bbrc.2010.07.078. Epub 2010 Jul 24. Biochem Biophys Res Commun. 2010. PMID: 20659425
A new regulatory mechanism of NF-kappaB activation by I-kappaBbeta in cancer cells.
Kim JM, Voll RE, Ko C, Kim DS, Park KS, Kim SY. Kim JM, et al. J Mol Biol. 2008 Dec 26;384(4):756-65. doi: 10.1016/j.jmb.2008.10.010. Epub 2008 Oct 11. J Mol Biol. 2008. PMID: 18950638
Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.
Park KS, Han BG, Lee KH, Kim DS, Kim JM, Jeon H, Kim HS, Suh SW, Lee EH, Kim SY, Lee BI. Park KS, et al. Cancer Lett. 2009 Feb 18;274(2):201-7. doi: 10.1016/j.canlet.2008.09.007. Epub 2008 Oct 11. Cancer Lett. 2009. PMID: 18851895
Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.
Kim DS, Park KS, Jeong KC, Lee BI, Lee CH, Kim SY. Kim DS, et al. Cancer Lett. 2009 Jan 18;273(2):243-9. doi: 10.1016/j.canlet.2008.08.015. Epub 2008 Sep 19. Cancer Lett. 2009. PMID: 18804908
3,715 results
Jump to page
Feedback